Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study

Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study

Abstract Introduction Individual variability of rivaroxaban was observed in clinical application. This study aimed to identify genetic variants associated with the variability of pharmacodynamics and bleeding risk of rivaroxbaban in patients with nonvalvular atrial fibrillation (NVAF). Materials and...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Qian Xiang, Zhe Wang, Guangyan Mu, Qiufen Xie, Zhiyan Liu, Shuang Zhou, Hanxu Zhang, Zining Wang, Jie Jiang, Kun Hu, Yatong Zhang, Zinan Zhao, Dongdong Yuan, Liping Guo, Tingting Wu, Jinhua Zhang, Na Wang, Jing Xiang, Zhichun Gu, Jianjun Sun, Yimin Cui
פורמט: Article
שפה:English
יצא לאור: Wiley 2023-05-01
סדרה:Clinical and Translational Medicine
נושאים:
atrial fibrillation
bleeding
genetic polymorphism
pharmacodynamics
rivaroxaban
גישה מקוונת:https://doi.org/10.1002/ctm2.1263

אינטרנט

https://doi.org/10.1002/ctm2.1263

פריטים דומים